AAAAAA
Results:
1-7
|
Results: 7
Authors:
Bramer, SL
Tata, PNV
Vengurlekar, SS
Brisson, JH
Citation: Sl. Bramer et al., Method for the quantitative analysis of cilostazol and its metabolites in human plasma using LC/MS/MS, J PHARM B, 26(4), 2001, pp. 637-650
Authors:
Tata, PNV
Fu, CHJ
Bramer, SL
Citation: Pnv. Tata et al., Determination of cilostazol and its metabolites in human urine by high performance liquid chromatography, J PHARM B, 24(3), 2001, pp. 381-389
Authors:
Fu, CHJ
Tata, PNV
Okada, K
Akiyama, H
Bramer, SL
Citation: Chj. Fu et al., Simultaneous quantitative determination of cilostazol and its metabolites in human plasma by high-performance liquid chromatography, J CHROMAT B, 728(2), 1999, pp. 251-262
Authors:
Tata, PNV
Schorno, KS
Cowart, TD
Bramer, SL
Citation: Pnv. Tata et al., LC/MS/MS analysis of vesnarinone and its principal metabolites in plasma and urine, J PHARM B, 18(6), 1999, pp. 1037-1045
Authors:
Whalen, RD
Tata, PNV
Burckart, GJ
Venkataramanan, R
Citation: Rd. Whalen et al., Species differences in the hepatic and intestinal metabolism of cyclosporine, XENOBIOTICA, 29(1), 1999, pp. 3-9
Authors:
Tata, PNV
Bramer, SL
Citation: Pnv. Tata et Sl. Bramer, High performance liquid chromatographic method for the analysis of omeprazole and 5-hydroxyomeprazole in human plasma, ANAL LETTER, 32(11), 1999, pp. 2285-2295
Authors:
Tata, PNV
Fu, CHJ
Browder, NJ
Chow, PC
Bramer, SL
Citation: Pnv. Tata et al., The quantitative determination of cilostazol and its four metabolites in human liver microsomal incubation mixtures by high-performance liquid chromatography, J PHARM B, 18(3), 1998, pp. 441-451
Risultati:
1-7
|